THE CHANGES OF SERUM COMPLEMENT LEVELS DURING PEGYRATED INTERFERON AND RIBAVIRIN THERAPY ARE CLOSELY ASSOCIATED WITH THE OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C

被引：0
|
作者：
Uchikoshi, Manabu [1 ]
Ito, Takayoshi [1 ]
Shimozuma, Yuu [1 ]
Inokuchi, Momoko [1 ]
Miyashita, Miyuki [1 ]
Hiroishi, Kazumasa [1 ]
Imawari, Michio [1 ]
机构：
[1] Showa Univ, Sch Med, Dept Med, Div Gastroenterol, Tokyo 142, Japan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1334A / 1335A
页数：2
相关论文
共 50 条
  • [1] Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
    Yoneda, Suguru
    Umemura, Takeji
    Joshita, Satoru
    Ichijo, Tetsuya
    Matsumoto, Akihiro
    Yoshizawa, Kaname
    Katsuyama, Yoshihiko
    Ota, Masao
    Tanaka, Eiji
    HEPATOLOGY RESEARCH, 2011, 41 (06) : 587 - 593
  • [2] Early prediction of development of severe anemia by serum ribavirin levels during interferon and ribavirin combination therapy for chronic hepatitis C
    Igarashi, H.
    Shinozaki, S.
    LIVER INTERNATIONAL, 2006, 26 : 78 - 79
  • [3] Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C
    Chaudhari, S
    Park, J
    Anand, BS
    Pimstone, NR
    Dieterich, DT
    Batash, S
    Bini, EJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S65 - S65
  • [4] Acute Pancreatitis Associated with Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C
    Swati Chaudhari
    James Park
    Bhupinderjit S. Anand
    Neville R. Pimstone
    Douglas T. Dieterich
    Steven Batash
    Edmund J. Bini
    Digestive Diseases and Sciences, 2004, 49 : 1000 - 1006
  • [5] Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C
    Chaudhari, S
    Park, J
    Anand, BS
    Pimstone, NR
    Dieterich, DT
    Batash, S
    Bini, EJ
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 1000 - 1006
  • [6] Chronic cough associated with interferon/ribavirin therapy for hepatitis C
    Dicpinigaitis, P. V.
    Weiner, F. R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 416 - 418
  • [7] Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin for chronic hepatitis C
    Ogana, G
    Tocco, A
    Garrucciu, G
    Branca, B
    Azara, V
    Manzoni, NE
    Deplano, A
    Solinas, A
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (03) : 254 - 255
  • [8] Lambda Interferon Serum Levels in Patients with Chronic Hepatitis C Virus Infection According to Their Response to Therapy with Pegylated Interferon and Ribavirin
    Torres, Claudio
    Brahm, Javier
    Venegas, Mauricio
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2014, 34 (02): : 106 - 110
  • [9] Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C
    Arase, Y
    Ikeda, K
    Tsubota, A
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    INTERVIROLOGY, 2005, 48 (2-3) : 138 - 144
  • [10] Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Bruchfeld, A
    Ståhle, L
    Andersson, J
    Schvarcz, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (08) : 1729 - 1729
12345